If you or someone you know has a diagnosis of schizophrenia or schizoaffective disorder:

You may qualify to participate in this study if you are:

• Between the ages of 18-65
• Experiencing troublesome symptoms of your illness within the last 12 months
• Willing to visit the study doctor or a member of the research team every two weeks for up to 2-1/2 years

The purpose of this study is to evaluate the long-term effectiveness of long-acting injectable risperidone compared to oral antipsychotic medication. You will have a 50/50 chance of receiving long-acting injectable risperidone.

There are no charges for any of the study procedures or for the study medications.

Compensation is available. Participation is voluntary.

If you have questions or would like more information, please contact:

Jane Kerr
Phone: 319-353-4955

Tim Holman
Phone 319-335-6769